GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jiangsu Hengrui Pharmaceuticals Co Ltd (SHSE:600276) » Definitions » 3-Year Revenue Growth Rate

Jiangsu Hengrui Pharmaceuticals Co (SHSE:600276) 3-Year Revenue Growth Rate : -6.00% (As of Mar. 2024)


View and export this data going back to 2000. Start your Free Trial

What is Jiangsu Hengrui Pharmaceuticals Co 3-Year Revenue Growth Rate?

Jiangsu Hengrui Pharmaceuticals Co's Revenue per Share for the three months ended in Mar. 2024 was ¥0.92.

During the past 12 months, Jiangsu Hengrui Pharmaceuticals Co's average Revenue per Share Growth Rate was 10.90% per year. During the past 3 years, the average Revenue per Share Growth Rate was -6.00% per year. During the past 5 years, the average Revenue per Share Growth Rate was 3.20% per year. During the past 10 years, the average Revenue per Share Growth Rate was 15.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of Jiangsu Hengrui Pharmaceuticals Co was 36.40% per year. The lowest was -6.00% per year. And the median was 21.35% per year.


Competitive Comparison of Jiangsu Hengrui Pharmaceuticals Co's 3-Year Revenue Growth Rate

For the Drug Manufacturers - General subindustry, Jiangsu Hengrui Pharmaceuticals Co's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Jiangsu Hengrui Pharmaceuticals Co's 3-Year Revenue Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Jiangsu Hengrui Pharmaceuticals Co's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Jiangsu Hengrui Pharmaceuticals Co's 3-Year Revenue Growth Rate falls into.



Jiangsu Hengrui Pharmaceuticals Co 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.


Jiangsu Hengrui Pharmaceuticals Co  (SHSE:600276) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.


Jiangsu Hengrui Pharmaceuticals Co 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Jiangsu Hengrui Pharmaceuticals Co's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Jiangsu Hengrui Pharmaceuticals Co (SHSE:600276) Business Description

Traded in Other Exchanges
N/A
Address
No. 38, Huanghe Road, Economic, Economic and Technological Development Zone, Jiangsu Province, Lianyugang, CHN, 222047
Jiangsu Hengrui Pharmaceuticals Co Ltd is engaged in the field of cancer treatment drugs, surgical medicines, endocrine therapy drugs, cardiovascular drugs and anti-infection medications. It specializes in the research and development of new medicines in areas of antineoplastics, endocrine system, cardiovascular, and the immune system.

Jiangsu Hengrui Pharmaceuticals Co (SHSE:600276) Headlines

No Headlines